CSCI
Price
$3.10
Change
-$0.01 (-0.32%)
Updated
Apr 24, 10:30 AM (EDT)
Capitalization
9.87M
SEER
Price
$2.00
Change
-$0.04 (-1.96%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
118.97M
19 days until earnings call
Ad is loading...

CSCI vs SEER

Header iconCSCI vs SEER Comparison
Open Charts CSCI vs SEERBanner chart's image
COSCIENS Biopharma
Price$3.10
Change-$0.01 (-0.32%)
VolumeN/A
Capitalization9.87M
Seer
Price$2.00
Change-$0.04 (-1.96%)
Volume$6.87K
Capitalization118.97M
CSCI vs SEER Comparison Chart
Loading...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSCI vs. SEER commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSCI is a Hold and SEER is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (CSCI: $3.11 vs. SEER: $2.04)
Brand notoriety: CSCI and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSCI: 30% vs. SEER: 37%
Market capitalization -- CSCI: $9.87M vs. SEER: $118.97M
CSCI [@Biotechnology] is valued at $9.87M. SEER’s [@Biotechnology] market capitalization is $118.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSCI’s FA Score shows that 0 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).

  • CSCI’s FA Score: 0 green, 5 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, SEER is a better buy in the long-term than CSCI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SEER’s TA Score shows that 5 TA indicator(s) are bullish.

  • SEER’s TA Score: 5 bullish, 6 bearish.

Price Growth

CSCI (@Biotechnology) experienced а +10.28% price change this week, while SEER (@Biotechnology) price change was +3.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

CSCI is expected to report earnings on Apr 09, 2025.

SEER is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SEER($119M) has a higher market cap than CSCI($9.87M). CSCI YTD gains are higher at: 12.274 vs. SEER (-11.688). CSCI has higher annual earnings (EBITDA): -9.89M vs. SEER (-93.93M). SEER has more cash in the bank: 236M vs. CSCI (20M). CSCI has less debt than SEER: CSCI (1.62M) vs SEER (26M). SEER has higher revenues than CSCI: SEER (13.9M) vs CSCI (7.6M).
CSCISEERCSCI / SEER
Capitalization9.87M119M8%
EBITDA-9.89M-93.93M11%
Gain YTD12.274-11.688-105%
P/E RatioN/AN/A-
Revenue7.6M13.9M55%
Total Cash20M236M8%
Total Debt1.62M26M6%
FUNDAMENTALS RATINGS
CSCI: Fundamental Ratings
CSCI
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SEER
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICWIX5.440.04
+0.74%
Integrity Mid-North American Resources I
MNVRX27.47N/A
N/A
Madison Large Cap R6
HFMIX23.26N/A
N/A
Hartford MidCap I
WFPDX9.74N/A
N/A
Allspring Premier Large Co Gr Adm
JTQRX14.37N/A
N/A
JHancock ESG International Equity R6

CSCI and

Correlation & Price change

A.I.dvisor tells us that CSCI and SLDB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSCI and SLDB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSCI
1D Price
Change %
CSCI100%
+2.47%
SLDB - CSCI
30%
Poorly correlated
+3.50%
JANX - CSCI
29%
Poorly correlated
+5.36%
ARDX - CSCI
29%
Poorly correlated
+0.52%
FATE - CSCI
27%
Poorly correlated
-2.55%
SEER - CSCI
27%
Poorly correlated
-2.39%
More